CA2020346A1 - Facteurs a1, a2, a3 et h de l'antibiotique ge 2270 - Google Patents

Facteurs a1, a2, a3 et h de l'antibiotique ge 2270

Info

Publication number
CA2020346A1
CA2020346A1 CA2020346A CA2020346A CA2020346A1 CA 2020346 A1 CA2020346 A1 CA 2020346A1 CA 2020346 A CA2020346 A CA 2020346A CA 2020346 A CA2020346 A CA 2020346A CA 2020346 A1 CA2020346 A1 CA 2020346A1
Authority
CA
Canada
Prior art keywords
antibiotic
factors
medicaments
directed
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2020346A
Other languages
English (en)
Other versions
CA2020346C (fr
Inventor
Enrico Selva
Paolo Tavecchia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicuron Pharmaceuticals LLC
Original Assignee
Gruppo Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of CA2020346A1 publication Critical patent/CA2020346A1/fr
Application granted granted Critical
Publication of CA2020346C publication Critical patent/CA2020346C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002020346A 1989-07-04 1990-07-03 Facteurs a1, a2, a3 et h de l'antibiotique ge 2270 Expired - Fee Related CA2020346C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89112171.7 1989-07-04
EP89112171 1989-07-04

Publications (2)

Publication Number Publication Date
CA2020346A1 true CA2020346A1 (fr) 1991-01-05
CA2020346C CA2020346C (fr) 2000-10-10

Family

ID=8201585

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002020346A Expired - Fee Related CA2020346C (fr) 1989-07-04 1990-07-03 Facteurs a1, a2, a3 et h de l'antibiotique ge 2270

Country Status (11)

Country Link
US (2) US5139778A (fr)
EP (1) EP0406745B1 (fr)
JP (1) JP2997510B2 (fr)
KR (1) KR0165673B1 (fr)
AT (1) ATE117724T1 (fr)
CA (1) CA2020346C (fr)
DE (1) DE69016284T2 (fr)
DK (1) DK0406745T3 (fr)
ES (1) ES2066914T3 (fr)
GR (1) GR3015052T3 (fr)
IE (1) IE67437B1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2066914T3 (es) * 1989-07-04 1995-03-16 Lepetit Spa Factores a1, a2, a3 y h del antibiotico ge 2270.
ES2071143T3 (es) * 1990-03-08 1995-06-16 Lepetit Spa Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
EP0529410B1 (fr) * 1991-08-30 1998-02-25 Biosearch Italia S.p.A. Facteur C2a de l'antibiotique CE 2270
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
CA2212437A1 (fr) 1995-02-07 1996-08-15 Biosearch Italia S.P.A. Derives basiques oxazoline-amides des antibiotiques ge 2270 ou similaires
ES2115424T3 (es) * 1995-02-07 1998-06-16 Biosearch Italia Spa Derivados prolin-amidicos basicos de los antibioticos ge 2270 y similares a ge 2270.
DE69718442T2 (de) * 1996-02-14 2003-04-30 Biosearch Italia S.P.A., Gerenzano Derivate des antibiotisch wirkenden faktors ge2270
KR20050026401A (ko) * 2002-06-17 2005-03-15 비큐론 파마세티컬스 인코포레이티드 여드름 치료를 위한 ｇｅ 2270 인자 ａ3의 아미드유도체의 용도
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
EA200900816A1 (ru) * 2006-12-20 2009-12-30 Новартис Аг Антибактериальные соединения и способы их получения
NZ585788A (en) 2007-12-12 2011-07-29 Novartis Ag Aminothiazoles and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR77567B (fr) * 1982-08-26 1984-09-24 Lepetit Spa
GB8323382D0 (en) * 1983-08-31 1983-10-05 Lepetit Spa Antibiotic sb 22484
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8821160D0 (en) * 1988-09-09 1988-10-12 Lepetit Spa Antibiotic ge 2270
ES2066914T3 (es) * 1989-07-04 1995-03-16 Lepetit Spa Factores a1, a2, a3 y h del antibiotico ge 2270.

Also Published As

Publication number Publication date
DK0406745T3 (da) 1995-02-27
IE902405A1 (en) 1991-06-19
ES2066914T3 (es) 1995-03-16
US5139778A (en) 1992-08-18
DE69016284T2 (de) 1995-05-24
JP2997510B2 (ja) 2000-01-11
CA2020346C (fr) 2000-10-10
EP0406745A1 (fr) 1991-01-09
ATE117724T1 (de) 1995-02-15
EP0406745B1 (fr) 1995-01-25
KR910003107A (ko) 1991-02-26
IE67437B1 (en) 1996-04-03
KR0165673B1 (ko) 1999-01-15
DE69016284D1 (de) 1995-03-09
US5547666A (en) 1996-08-20
GR3015052T3 (en) 1995-05-31
JPH0363289A (ja) 1991-03-19

Similar Documents

Publication Publication Date Title
CA2068324A1 (fr) Compositions peptidiques renfermant un metal et methodes de stimulation de la croissance des cheveux
CA2067381A1 (fr) Traitement des infections a vih et composes utiles a cet egard
IE863381L (en) Antibiotics
IE863382L (en) Antibiotics
GR3015052T3 (en) Antibiotic GE 2270 factors A1, A2, A3 and H.
CA2037779A1 (fr) Antibiotique ge 2270, facteurs b1, b2, c1, c2, d1, d2, e et t
AU6697786A (en) New derivatives of 1-sulphonyl 2-oxo-5-alkoxy pyrrolidine, their preparation process, their use as medicaments and the compositions containing them
EP0328924A3 (fr) Composés de thiénotriazolodiazépine et ses applications pharmaceutiques
CA2205573A1 (fr) Benzamide peristaltique
CA2077102A1 (fr) Antibiotique ge 2270 facteur c2a
AU660296B2 (en) Pharmaceutical compositions containing functionalized vinylazoles, use of these vinylazoles for producing medicaments, these vinylazoles themselves and process for producing the same
AU8127991A (en) Novel derivatives of 1-diphenylmethyl piperazine, their preparation and their use as medicaments
EP0359062A3 (fr) Antibiotique GE 2270
GR3026590T3 (en) Antibiotics ge 37468 a, b and c.
CA2034926A1 (fr) Methode et compositions pour le traitement des intoxications
CA2101548A1 (fr) Acides acylamino-alylidenehydroxy-bisphosphoniques, utiles pour le traitement des maladies osteoarticulaires
CA2138288A1 (fr) Derives azabicycloheptane substitues, leur preparation et leur utilisation
AU6492890A (en) Furosemide salts, preparation process, use as medicaments and pharmaceutical compositions containing them
AU6725387A (en) Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed